State NC
Clinical Trials in North Carolina
North Carolina is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in North Carolina and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 372 actively recruiting studies with North Carolina sites out of 372 registered in total. The busiest research areas in North Carolina are Breast Cancer, Heart Failure, Multiple Myeloma. Leading sponsors running trials in the state include Duke University, Wake Forest University Health Sciences, UNC Lineberger Comprehensive Cancer Center. By stage, North Carolina trials break down as Phase 1 (61), Phase 2 (94), Phase 3 (79), Phase 4 (12).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in North Carolina
Frequently Asked Questions — Clinical Trials in North Carolina
How many clinical trials are currently recruiting in North Carolina?
ClinicalMetric currently tracks 372 actively recruiting clinical trials with at least one location in North Carolina. The total number of registered studies—including active but not currently enrolling trials—is 372. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in North Carolina?
North Carolina hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Heart Failure, Multiple Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout North Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in North Carolina?
To join a clinical trial in North Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in North Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in North Carolina
NCT05558059 N/A
Recruiting
Imaging Retinal Vasculature in Infant Eyes
Condition
Retinopathy of Prematurity
Enrollment
16 pts
Location
United States
Sponsor
Duke University
NCT06619990 Phase 1, Phase 2
Recruiting
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Coliti...
Condition
Ulcerative Colitis (UC)
Enrollment
270 pts
Location
United States, Argentina, Australia
Sponsor
Xencor, Inc.
NCT07339423 Phase 3
Recruiting
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...
Condition
Obesity
Enrollment
1,150 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT07602855 Phase 1, Phase 2
Recruiting
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants ...
Condition
Neoplasms, Lung
Enrollment
184 pts
Location
United States, Japan
Sponsor
GlaxoSmithKline
NCT03947385 Phase 1, Phase 2
Recruiting
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRK...
Condition
Metastatic Uveal Melanoma
Enrollment
336 pts
Location
United States, Australia, Canada
Sponsor
IDEAYA Biosciences
NCT06425848 N/A
Recruiting
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Condition
Heart Failure
Enrollment
2,000 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT04372615 Phase 2
Recruiting
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Condition
Autoimmune Encephalitis
Enrollment
116 pts
Location
United States, Netherlands, Spain
Sponsor
University of Utah
NCT05701917 N/A
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombos...
Condition
Venous Thromboembolism
Enrollment
300 pts
Location
United States, Austria, Finland
Sponsor
Inari Medical
NCT07118358 N/A
Recruiting
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Condition
Leadless Pacemaker
Enrollment
325 pts
Location
United States, Australia, Austria
Sponsor
Biotronik, Inc.
NCT06709404 N/A
Recruiting
Telehealth Intervention for Improving Distress and Financial Toxicity in the Car...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
50 pts
Location
United States
Sponsor
Wake Forest University Health
NCT07629440 Phase 3
Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Condition
Pneumococcal Disease
Enrollment
3,230 pts
Location
United States, Japan, Puerto Rico
Sponsor
Pfizer
NCT06222580 Phase 1
Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Muta...
Condition
Acute Myeloid Leukemia With FLT3/ITD Mutation
Enrollment
30 pts
Location
United States
Sponsor
Uma Borate
NCT07583940 N/A
Recruiting
Low Energy Availability and Hypertension in Division I HBCU Athletes
Condition
Vascular Stiffness
Enrollment
150 pts
Location
United States
Sponsor
North Carolina Agriculture & T
NCT06312176 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combinatio...
Condition
Breast Neoplasms
Enrollment
1,200 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05058508 N/A
Recruiting
LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
Condition
Pediatric Cancer
Enrollment
60 pts
Location
United States
Sponsor
Wake Forest University Health
NCT05799599 N/A
Recruiting
Peer Interventions for Preschoolers With Autism
Condition
Autism Spectrum Disorder
Enrollment
132 pts
Location
United States
Sponsor
University of Kansas
NCT07009093 N/A
Recruiting
Utility of a Mobile Application for Young Women With Breast Cancer
Condition
Breast Cancer
Enrollment
120 pts
Location
United States
Sponsor
Wake Forest University Health
NCT07574593 N/A
Recruiting
NORM-HF Pivotal Study
Condition
Heart Failure
Enrollment
800 pts
Location
United States
Sponsor
Foundry Innovation & Research
NCT06030063 N/A
Recruiting
The Society for Obstetric Anesthesia and Perinatology Research Network General A...
Condition
Cesarean Delivery
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Yale University
NCT06965504 N/A
Recruiting
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure ...
Condition
Heart Failure
Enrollment
250 pts
Location
United States
Sponsor
Abiomed Inc.
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
NCT06896916 Phase 1
Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cerebl...
Condition
Multiple Myeloma
Enrollment
135 pts
Location
United States, Australia, Canada
Sponsor
AbbVie
NCT06747117 N/A
Recruiting
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus ...
Condition
Lower Extremity Acute Limb Ischemia
Enrollment
300 pts
Location
United States, Australia, Brazil
Sponsor
Penumbra Inc.
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT04792489 Phase 2
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
Condition
Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Enrollment
315 pts
Location
United States, Canada
Sponsor
Miltenyi Biomedicine GmbH
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology